Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos One|May 29, 2014
Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathwayIleabett M Echevarría-Vargas, Fatma Valiyeva, Pablo E Vivas-Mejía
Proteins|October 13, 2011
A genetically encoded, high-signal-to-noise maltose sensorJonathan S Marvin, Eric R Schreiter, Ileabett M Echevarría, et al.
Oncotarget|May 12, 2016
Targeting miR-21-3p inhibits proliferation and invasion of ovarian cancer cellsPerla M Báez-Vega, Ileabett M Echevarría Vargas, Fatma Valiyeva, et al.
Molecular Cancer Therapeutics|August 1, 2015
Targeting c-MYC in Platinum-Resistant Ovarian CancerJeyshka M Reyes-González, Guillermo N Armaiz-Peña, Lingegowda S Mangala, et al.
American Journal of Translational Research|May 2, 2020
Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cellsYasmarie Santana-Rivera, Robert J Rabelo-Fernández, Blanca I Quiñones-Díaz, et al.
American Journal of Translational Research|December 27, 2021
Erratum: Reduced expression of enolase-1 correlates with high intracellular glucose levels and increased senescence in cisplatin-resistant ovarian cancer cellsYasmarie Santana-Rivera, Robert J Rabelo-Fernández, Blanca I Quiñones-Díaz, et al.
EMBO Molecular Medicine|April 14, 2018
Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanomaIleabett M Echevarría-Vargas, Patricia I Reyes-Uribe, Adam N Guterres, et al.
Pageof 1